Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by-nc-nd (c) Georg Thieme Verlag, 2019
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/163383

Successful outcomes of a new combined solution of hyaluronic acid, chondroitin sulfate and poloxamer 407 for submucosal injection: animal survival study

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Background: and study aims Endoscopic resection requires use of submucosal injection. This study was conducted to assess efficacy and impact on early healing of hyaluronic acid combined with chondroitin sulfate and poloxamer 407 (Ziverel) when used as a solution for submucosal injection. Materials: and methods Prospective and comparative study of gastric endoscopic mucosal resection (EMR) with three groups of two Yorkshire pigs. Six submucosal cushions were created in each animal by injecting 2 mL of Ziverel (Group 1) or succinylated gelatin (SG) (Group 2), enabling 12 EMR in each group. Submucosal cushions were created with Ziverel in Group 3, without resection. Electrosurgery unit settings were the same in all cases. EMR defects and injection sites were marked with clips. The animals were sacrificed 7 days later. EMR specimen size and duration of procedure were recorded. EMR specimens and EMR scars and injection sites were evaluated by a blinded pathologist. Results: We successfully performed 24 EMR (15 en-bloc and 9 piecemeal, without differences between groups 1 and 2). Mean EMR specimen dimensions were significantly larger in Group 1 (median 19 mm, range 6 - 40 vs 16.6 mm, range 5‑25; P = 0.019), without changing the electrocautery unit settings. Blinded histopathologist assessment of EMR specimens showed less fibrosis in the submucosa and a trend to fewer cautery artifacts with Ziverel and did not identify any significant differences in early healing of resection sites. Conclusion: The combination of Ziverel enables EMR and does not negatively affect early healing.

Citació

Citació

CÓRDOVA, Henry, CUATRECASAS FREIXAS, Miriam, GARCÍA-RODRÍGUEZ, Ana, MONTENEGRO, Andrea, MELO, Jordana, RODRÍGUEZ DE MIGUEL, Cristina, MARTÍNEZ PALLI, Graciela, GARCÉS-DURÁN, Rodrigo, LLACH VILA, Josep, FERNÁNDEZ ESPARRACH, Glòria. Successful outcomes of a new combined solution of hyaluronic acid, chondroitin sulfate and poloxamer 407 for submucosal injection: animal survival study. _Endoscopy International Open_. 2019. Vol. 7, núm. 4, pàgs. E576-E582. [consulta: 7 de febrer de 2026]. ISSN: 2364-3722. [Disponible a: https://hdl.handle.net/2445/163383]

Exportar metadades

JSON - METS

Compartir registre